Basilea Pharmaceutica Aktie
40,60CHF | 0,25CHF | 0,62% |
WKN: A0B9GA / ISIN: CH0011432447
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 91,71 |
Basilea Pharmaceutica AG | 8,29 |
Black Creek Investment Management, Inc. | 4,91 |
CI Investments, Inc. | 4,88 |
Braginsky Family Office AG | 2,97 |
Acatis Datini Valueflex Fonds | 2,52 |
Government Pension Fund - Global (The) | 2,00 |
United Financial-International Equity Alpha Corporate Class | 1,87 |
Vanguard Total International Stock Index Fund | 1,29 |
Swisscanto (CH) Index Fund V - Equity Fd. Switzerland To. Res. | 0,84 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 225 | 150 | 154 | 154 | 147 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,60 | 0,85 | 0,96 | 0,96 | 1,07 |
Bilanz (in Mio. CHF) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 185 | 224 | 241 | 175 | 152 |
Summe Anlagevermögen | 37 | 6 | 6 | 45 | 21 |
Summe Aktiva | 221 | 230 | 247 | 221 | 173 |
Bilanz (in Mio. CHF) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 198 | 242 | 219 | 187 | 129 |
Summe Fremdkapital | 314 | 332 | 306 | 242 | 183 |
Summe Eigenkapital | -93 | -102 | -59 | -21 | -10 |
Summe Passiva | 221 | 230 | 247 | 221 | 173 |
Adresse
Hegenheimermattweg 167b, 4123 Allschwil | |
Telefon | +41 (61) 606-11-11 |
Internet | http://www.basilea.com |
Management
Adesh Kaul
Chief Financial Officer |
Alf Gunnar Martin Nicklasson
Independent Non-Executive Director |
Carole A. Sable
Director |
Damian Heller
Secretary & General Counsel |
David Veitch
Chief Executive Officer |
Domenico Scala
Chairman |
Gerrit Hauck
Chief Technology Officer |
Laurenz Kellenberger
Chief Scientific Officer |
Leonard Kruimer
Independent Director |
Marc Engelhardt
Chief Medical Officer |
Nicole M. Onetto
Independent Non-Executive Director |
Peer Nils Schröder
Head-Corporate Communications & Investor Relations |
Thomas Werner
Vice Chairman |
Ursula Eberhardt
Head-Global Human Resources |